iShares Nasdaq Biotechnology Index Fund ETF News

Biotech stocks moved higher last week along with the broader market. The week witnessed a few clinical readouts and pre-announcements that reflected the coronavirus (COVID-19...

They're already beating the market. And they still have lots of room to run.

Carroll Financial Associates Inc. lowered its stake in iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) by 5.2% during the first quarter, according to the company in its most recent filing with the SEC.

The Fed injected another 2.3 trillion into buying bonds including junk. The Fed has bypassed the Federal Reserve act, which means they can buy whatever they want. Equity ETFs may be next.

As companies announce the marketing or development of diagnostic tests for the new coronavirus, they invariably reference an Emergency Use Authorization, or EUA. U.S.-based Co-...

The market remains unsettled but is moving higher as it expects good things to happen after the hot spots peak. The impact of the pandemic will keep expanding d

The enormity of the coronavirus pandemic has forced biopharma companies to step up efforts to expeditiously develop vaccines and treatments for COVID-19.  The...

COVID-19 has turned our world upside down. From the way we travel to how we work, American life is entering a new normal.

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs April 8) Keros Therapeutics Inc (...

KRE was the first to fall into a caution phase in January. A while ago, we fathomed that it stands to reason it should also be the first to show a true bottom. At this point, KRE is the lowest common

These strong biotech performers are benefiting from impressive drug pipelines rather than speculation about a virus cure.

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 7) Dr.Reddy's Laboratories...

Lake Street Financial LLC acquired a new position in iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) in the 1st quarter, according to the company in its most recent filing with the Securities and Exchan

The Russell 2000 IWM weekly chart has helped us navigate the bull and bear runs for years.

Inovio stock is up on hopes of solving the coronavirus puzzle. But INO stock has plenty of competition in that regard.